Total Neoadjuvant Therapy With Induction Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma
Latest Information Update: 13 Jan 2025
Price :
$35 *
At a glance
- Drugs Tislelizumab (Primary) ; Cisplatin; Paclitaxel
- Indications Carcinoma; Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms NICE-ESCC
- 13 Jan 2025 New trial record